Search

Theodore J. Criares

Examiner (ID: 9047)

Most Active Art Unit
1205
Art Unit(s)
1617, 2614, 1205, 1614, 2899, 1621
Total Applications
1571
Issued Applications
1017
Pending Applications
197
Abandoned Applications
357

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3661909 [patent_doc_number] => 05648396 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Methods for treating depression and other disorders using optically pure R (-) fluoxetine and monoamine oxidase inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/486056 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7809 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648396.pdf [firstpage_image] =>[orig_patent_app_number] => 486056 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/486056
Methods for treating depression and other disorders using optically pure R (-) fluoxetine and monoamine oxidase inhibitor Jun 6, 1995 Issued
Array ( [id] => 3643297 [patent_doc_number] => 05628982 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Hydroxy-aryl metal chelates for diagnostic NMR imaging' [patent_app_type] => 1 [patent_app_number] => 8/466471 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6135 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/628/05628982.pdf [firstpage_image] =>[orig_patent_app_number] => 466471 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/466471
Hydroxy-aryl metal chelates for diagnostic NMR imaging Jun 5, 1995 Issued
Array ( [id] => 3687125 [patent_doc_number] => 05663188 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Synergistic therapeutic compositions of angiotensin I converting enzyme inhibitors and angiotensin II antagonists and methods' [patent_app_type] => 1 [patent_app_number] => 8/468505 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4794 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663188.pdf [firstpage_image] =>[orig_patent_app_number] => 468505 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/468505
Synergistic therapeutic compositions of angiotensin I converting enzyme inhibitors and angiotensin II antagonists and methods Jun 5, 1995 Issued
Array ( [id] => 3842631 [patent_doc_number] => 05707981 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Synergistic pharmaceutical compositions' [patent_app_type] => 1 [patent_app_number] => 8/469371 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 36 [patent_no_of_words] => 1669 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/707/05707981.pdf [firstpage_image] =>[orig_patent_app_number] => 469371 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/469371
Synergistic pharmaceutical compositions Jun 5, 1995 Issued
Array ( [id] => 3715717 [patent_doc_number] => 05616571 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Bisphosphonates prevent bone loss associated with immunosuppressive therapy' [patent_app_type] => 1 [patent_app_number] => 8/471466 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1380 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616571.pdf [firstpage_image] =>[orig_patent_app_number] => 471466 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/471466
Bisphosphonates prevent bone loss associated with immunosuppressive therapy Jun 5, 1995 Issued
08/471111 METHODS FOR MINIMIZING BONE LOSS Jun 5, 1995 Abandoned
Array ( [id] => 3874833 [patent_doc_number] => 05824693 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Method for treatment for pulmonary disease' [patent_app_type] => 1 [patent_app_number] => 8/470094 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2569 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824693.pdf [firstpage_image] =>[orig_patent_app_number] => 470094 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/470094
Method for treatment for pulmonary disease Jun 5, 1995 Issued
Array ( [id] => 1009472 [patent_doc_number] => 06900234 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-31 [patent_title] => 'Synergistic therapeutic compositions and methods' [patent_app_type] => utility [patent_app_number] => 08/463878 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4817 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/900/06900234.pdf [firstpage_image] =>[orig_patent_app_number] => 08463878 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/463878
Synergistic therapeutic compositions and methods Jun 4, 1995 Issued
Array ( [id] => 4217066 [patent_doc_number] => 06110951 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Thiazolidine derivatives for the treatment of hypertension' [patent_app_type] => 1 [patent_app_number] => 8/463464 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10387 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110951.pdf [firstpage_image] =>[orig_patent_app_number] => 463464 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/463464
Thiazolidine derivatives for the treatment of hypertension Jun 4, 1995 Issued
Array ( [id] => 1206064 [patent_doc_number] => 06716875 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-06 [patent_title] => 'Synergistic therapeutic compositions of ACE and renin inhibitors and methods' [patent_app_type] => B1 [patent_app_number] => 08/465660 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4808 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716875.pdf [firstpage_image] =>[orig_patent_app_number] => 08465660 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/465660
Synergistic therapeutic compositions of ACE and renin inhibitors and methods Jun 4, 1995 Issued
Array ( [id] => 4108408 [patent_doc_number] => 06022897 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof' [patent_app_type] => 1 [patent_app_number] => 8/465375 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8739 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 289 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022897.pdf [firstpage_image] =>[orig_patent_app_number] => 465375 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/465375
Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof Jun 4, 1995 Issued
Array ( [id] => 3838771 [patent_doc_number] => 05847002 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and NSAID' [patent_app_type] => 1 [patent_app_number] => 8/461123 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 7855 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/847/05847002.pdf [firstpage_image] =>[orig_patent_app_number] => 461123 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/461123
Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and NSAID Jun 4, 1995 Issued
Array ( [id] => 3657579 [patent_doc_number] => 05622973 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Treatment of osteoporosis with substituted piperidines, pyrrolidines and hexahydro-1H-azepines in combination with bisphosphonates' [patent_app_type] => 1 [patent_app_number] => 8/464982 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32279 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622973.pdf [firstpage_image] =>[orig_patent_app_number] => 464982 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/464982
Treatment of osteoporosis with substituted piperidines, pyrrolidines and hexahydro-1H-azepines in combination with bisphosphonates Jun 4, 1995 Issued
Array ( [id] => 3648400 [patent_doc_number] => 05629318 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Method of treatment of chronic prostatitis with 17.beta.-N-monosubstituted-carbamoyl-4-aza-5.alpha.-androst-1-en-3-ones' [patent_app_type] => 1 [patent_app_number] => 8/448451 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6162 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/629/05629318.pdf [firstpage_image] =>[orig_patent_app_number] => 448451 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/448451
Method of treatment of chronic prostatitis with 17.beta.-N-monosubstituted-carbamoyl-4-aza-5.alpha.-androst-1-en-3-ones Jun 1, 1995 Issued
Array ( [id] => 3647348 [patent_doc_number] => 05637620 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Micro formoterol particles' [patent_app_type] => 1 [patent_app_number] => 8/459660 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2857 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637620.pdf [firstpage_image] =>[orig_patent_app_number] => 459660 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/459660
Micro formoterol particles Jun 1, 1995 Issued
Array ( [id] => 3571638 [patent_doc_number] => 05538970 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-23 [patent_title] => 'Treatment of cancer with imidazo-1,2-pyridazin compounds' [patent_app_type] => 1 [patent_app_number] => 8/458225 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19679 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/538/05538970.pdf [firstpage_image] =>[orig_patent_app_number] => 458225 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/458225
Treatment of cancer with imidazo-1,2-pyridazin compounds Jun 1, 1995 Issued
08/458195 USE OF ALENDRONATE FOR THE PREVENTION OF OSTEOPOROSIS Jun 1, 1995 Abandoned
Array ( [id] => 3984135 [patent_doc_number] => 05958959 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Treatment of platelet derived growth factor related disorders such as cancers' [patent_app_type] => 1 [patent_app_number] => 8/457051 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 39322 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958959.pdf [firstpage_image] =>[orig_patent_app_number] => 457051 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/457051
Treatment of platelet derived growth factor related disorders such as cancers May 31, 1995 Issued
Array ( [id] => 3829377 [patent_doc_number] => 05739138 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => 'Enantiomerically pure hydroxylated xanthine compounds to treat autoimmune diabetes' [patent_app_type] => 1 [patent_app_number] => 8/457703 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16592 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/739/05739138.pdf [firstpage_image] =>[orig_patent_app_number] => 457703 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/457703
Enantiomerically pure hydroxylated xanthine compounds to treat autoimmune diabetes May 31, 1995 Issued
Array ( [id] => 3860059 [patent_doc_number] => 05792772 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Enatiomerically pure hydroxylated xanthine compounds' [patent_app_type] => 1 [patent_app_number] => 8/458957 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16541 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792772.pdf [firstpage_image] =>[orig_patent_app_number] => 458957 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/458957
Enatiomerically pure hydroxylated xanthine compounds May 31, 1995 Issued
Menu